Tag Archives: biotechnology law

From The EPO: Oral Proceedings/Interviews Before Examining Division Can Be Held Via Videoconferencing

This is a guest post from Lynnea Fedyk, legal process assistant at Schwegman, Lundberg & Woessner, P.A. Attached are two documents of particular interest regarding Oral Proceedings by video conference and submission of email during video conference. Should you like to … Continue reading

Posted in EP and UK Practice | Tagged , , , , , , | Leave a comment

Prometheus Unbound – Are Methods Of Medical Treatment The Next “Targets”?

In my March post “Unnatural Acts – Patenting Diagnostic Tests Post-Prometheus” I wrote: “I have been trying to formulate diagnostic claims that would pass muster post-Prometheus and I am having trouble. If a researcher discovers the marker, the researcher should … Continue reading

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , , , | 2 Comments

SLW Invites You To A Free Webinar – America Invents Act: What Corporate Counsel Need To Know

Please join Schwegman, Lundberg & Woessner, P.A. for an hour-long discussion on how combining litigation, reexamination, and interference results in the USPTO’s new adversarial proceedings: inter partes review and post-grant review. The AIA offers these proceedings to provide efficient patentability … Continue reading

Posted in Conferences and Classes | Tagged , , , , , , , , , , , , | Leave a comment

USPTO Institutes “QUICK PATH” IDS PILOT Program

The USPTO has announced the implementation of a pilot program, effective from May 16th until September 30th, to permit applicants to file IDS statements after payment of the issue fee in utility and reissue applications, without the need to continue … Continue reading

Posted in USPTO Practice and Policy | Tagged , , , , , , , , , , , , | Leave a comment